Authors

Authors

Carolyn V. Gould, MD, MSCR

Division of Healthcare Quality Promotion

Centers for Disease Control and Prevention

Atlanta, GA

Craig A. Umscheid, MD, MSCE

Rajender K. Agarwal, MD, MPH

Gretchen Kuntz, MSW, MSLIS

Center for Evidence-based Practice

University of Pennsylvania Health System

Philadelphia, PA

David A. Pegues, MD

Division of Infectious Diseases

David Geffen School of Medicine at UCLA

Los Angeles, CA

and the Healthcare Infection Control Practices Advisory Committee (HICPAC)

Healthcare Infection Control Practices Advisory Committee (HICPAC)

Chair

BRENNAN, Patrick J., MD

Chief Medical Officer

Division of Infectious Diseases

University of Pennsylvania Health System

Executive Secretary

BELL, Michael R., MD

Associate Director for Infection Control

Division of Healthcare Quality Promotion

National Center for Infectious Diseases

Centers for Disease Control and Prevention

Members

BURNS, Lillian A., MPH

Infection Control Coordinator

Infectious Diseases Department

Greenwich Hospital

ELWARD, Alexis, MD, MPH

Medical Director of Infection Control

Assistant Professor, Pediatric Infectious Diseases

Washington University School of Medicine

ENGEL, Jeffrey, MD

Chief, Epidemiology Section, North Carolina Division of Public Health

North Carolina State Epidemiologist

LUNDSTROM, Tammy, MD, JD

Chief Medical Officer

Providence Hospital

GORDON, Steven M., MD

Chairman, Department of Infectious Diseases

Hospital Epidemiologist

Cleveland Clinic Foundation

MCCARTER, Yvette S., PhD

Director, Clinical Microbiology

Laboratory Department of Pathology

University of Florida Health Science Center-Jacksonville

MURPHY, Denise M., MPH, RN, CIC

Vice President, Safety and Quality

Barnes-Jewish Hospital at Washington

University Medical Center

OLMSTED, Russell N., MPH

Epidemiologist

Infection Control Services

St. Joseph Mercy Health System

PEGUES, David Alexander, MD

Professor of Medicine, Hospital Epidemiologist

David Geffen School of Medicine at UCLA

RAMSEY, Keith M., MD

Professor of Medicine

Medical Director of Infection Control

Pitt County Memorial

SINGH, Nalini, MD, MPH

Professor of Pediatrics

Epidemiology and International Health

George Washington University

Children's National Medical Center

SOULE, Barbara M., RN, MPA, CIC

Practice Leader

Infection Prevention Services

Joint Commission Resources/Joint Commission International

SCHECTER, William, P., MD

Department of Surgery, Ward 3A 17

San Francisco General Hospital

STEVENSON, Kurt Brown, MD, MPH

Division of Infectious Diseases

Department of Internal Medicine

The Ohio State University Medical Center

Ex-officio Members

Agency for Healthcare Research and Quality

Ex-Officio

BAINE, William B., MD

Senior Medical Advisor

Center for Outcomes and Evidence

Agency for Healthcare Research and Quality

National Institute of Health

Ex-Officio

HENDERSON, David, MD

Deputy Director for Clinical Care

National Institute of Health

Health Resources and Services Administration

Ex-Officio

JAY, Lorine J., MPH, RN, CPHQ

Regional Coordinator

Food and Drug Administration

Ex-Officio

MURPHEY, Sheila A., MD

Chief, Infection Control Devices Branch

Division of Anesthesiology, General Hospital Infection Control and Dental Devices

Center for Devices and Radiology Health

Food and Drug Administration

Center for Medicare & Medicaid Services (CMS)

Ex-Officio

MILLER, Jeannie RN, MPH

Deputy Director, Office of Clinical Standards and Quality/ Clinical Standards Group

Department of Veterans Affairs (VA)

ROSELLE, Gary A., MD

National Program Director, Infectious Diseases

VA Central Office

Cincinnati VA Medical Center

Liaisons

Association of Professionals of Infection Control and Epidemiology, Inc.

BJERKE, Nancy BSN, RN, MPH, CIC

Infection Control Consultant

Infection Control Associates

Council of State and Territorial Epidemiologists

KAINER, Marion MD, MPH

Medical Epidemiologist/Infections

Diseases Physician Director, Hospital

Infections and Antimicrobial Resistance

Program, Tennessee Department of Health

American Health Care Association

FITZLER, Sandra L., RN

Senior Director of Clinical Services

American Health Care Association

American College of Occupational and Environmental Medicine

RUSSI, Mark, MD, MPH

American College of Occupational and Environmental Medicine

Advisory Council for the Elimination of Tuberculosis

STRICOF, Rachel L., MPH

New York State Department of Health

American Hospital Association

SCHULMAN, Roslyne, MHA, MBA

Senior Associate Director, Policy Development

Association of periOperative Registered Nurses

BLANCHARD, Joan C., RN, BSN, MSS, CNOR, CIC

Association of periOperative Registered Nurses

Society for Healthcare Epidemiology of America

MARAGAKIS, Lisa, MD

Assistant Professor of Medicine

Johns Hopkins Medical Institutions

Joint Commission on Accreditation of Healthcare Organizations

WISE, Robert A., MD

Division of Standards & Survey Methods

Joint Commission on Accreditation of Healthcare Organizations

Consumers Union

MCGIFFERT, Lisa

Senior Policy Analyst on Health Issues

Project Director

Stop Hospital Infections Organization

Acknowledgement

HICPAC thanks the following members who served on the HICPAC CAUTI Guideline subcommittee during the guideline development process: Russell N. Olmsted, MPH, Yvette S. McCarter, PhD, Barbara M. Soule, RN, MPA, CIC, and Nalini Singh, MD, MPH.HICPAC thanks the following outside experts for reviewing a draft of this guideline: Edward S. Wong, MD, Lindsay E. Nicolle, MD, Anthony J. Schaeffer, MD, and Harriett M. Pitt, RN, MS, CIC. The opinions of the reviewers might not be reflected in all the recommendations contained in this document. HICPAC would also like to thank the many individuals and organizations who provided valuable feedback on the guideline during the public comment period.

Disclosure of Financial Interests and Relationships

The authors C.V.G., C.A.U., R.K.A., and G.K. report no actual or potential conflicts of interest. D.A.P. is on the Speakers Bureau of Merck, Pfizer, Schering, and Cubist and is a consultant for Dow Pharmaceuticals, DaVita, and Vasonova. C.A.U. and R.K.A. received funding from the CDC to support the guideline development process.